Planatome, LLC, is a medical device technology company that has adapted nano-polishing technology from the semiconductor industry and patented it for surgical cutting instruments.
Inspired by our commitment to help achieve the best possible surgical outcomes for patients, Planatome nano-polishing represents the first advancement in surgical blades in over 100 years. Planatome nano-polishing achieves near molecular blade perfection, creating smooth edges that enable clean, highly precise, low-trauma incisions for unprecedented clinical results, benefiting patients, surgeons, and healthcare facilities.1-3
A compelling clinical and business case study for applying nano-polishing to all surgical cutting edges, the Planatome flagship scalpel delivers significant, clinically proven results, including minimized tissue trauma, increased comfort, faster healing, and reduced scarring.1-9 Superior performance, durability, and cost efficiency are driving the rapid adoption of these scalpels by surgeons and healthcare facilities.2,10
Recognizing the clinical, economic, and competitive advantages, medical manufacturers are rapidly licensing and deploying Planatome nano-polishing across a variety of surgical cutting tools (eg, scalpels, scissors, MIP shears, rongeurs, and robotics).
For over 25 years, Tim has held various leadership, sales, and technical roles in the semiconductor industry, including at Motorola, SpeedFam-IPEC, and Metron Technology. He co-founded Entrepix, Inc. Tim holds a Master of Science degree in Microelectronic Engineering from the Rochester Institute of Technology and a Bachelor of Science degree in Applied Physics from the State University of New York at Geneseo.
With over 30 years in the medical device industry, Bill has held various executive leadership, operations, and R&D roles, the majority of which were at Johnson & Johnson, primarily within J&J’s Ethicon Division. Bill was also part of the executive team that took Ulthera, Inc., an aesthetic device company, from start-up to a $600 million acquisition by Merz Pharma Group. Post-acquisition, he remained as CEO of Merz’s US-based Device Integration Center before re-entering the start-up medical device world. Bill holds a Bachelor of Science degree in Civil Engineering from The University of Akron.
Keith is an accomplished executive leader with over 20 years of experience in start-ups, private, and public companies, including leadership and R&D roles (eg, CEO, Oryx Additive; Sr. R&D Leader, Merz Pharma; Assoc. Director R&D, Johnson & Johnson). Keith earned his Doctor of Engineering Management and Systems degree from George Washington University, his MBA from Troy University, and his Bachelor of Science in Polymer Engineering from Penn State University. He also attained a Certification in Innovation and Strategy from MIT and an Apprentice Bladesmith Certification from the American Bladesmith Society (ABS).
As CFO and COO of private and public companies for over 20 years, including Action Performance Companies, Inc., VoDaVi Technologies, Inc., and Calance, LLC, David helped guide these companies through successful acquisitions. A Certified Public Accountant in the State of Arizona, David received his Bachelor of Science in Finance & Accounting from Humboldt State University.
Craig is a seasoned executive with over 25 years of experience in the global medical device market. As Director of Sales and Marketing at JJKK (Japan) and Director of Market Development at Ethicon Endo-Surgery, Craig drove commercial strategy and market expansion. As VP of Sales at Ulthera, Inc., he helped propel the company from start-up to acquisition. Most recently, as VP of Sales and Marketing at GT Medical Technologies, Craig launched GammaTile for the treatment of malignant brain tumors. He attended the Executive Program at Columbia Business School and received his Bachelor of Science in Business Administration and Organizational Behavior from San Diego State University.
